CompletedNCT05354583
Treatment Outcome Between Mycobacterium Abscessus Infection in Chronic Lung Disease and Acquired Interferon-gamma Autoantibody Syndrome
Studying Adult-onset immunodeficiency with anti-interferon-gamma autoantibodies
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- King Chulalongkorn Memorial Hospital
- Principal Investigator
- Warat Usawakidwiree, M.D.Department of Internal Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
- Intervention
- Appropriate treatment(drug)
- Enrollment
- 36 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2022 – 2023
Study locations (1)
- King Chulalongkorn Memorial Hospital, Pathum Wan, Bangkok, Thailand
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05354583 on ClinicalTrials.gov